|
Method of correction of phlogistic organopathologies of reproductive system of laying hens Method of correction of phlogistic organopathologies of reproductive system of laying hens includes supply with drinking water of the additive Malavit diluted in ratio 1:5000 which is given to laying hens in age from 300 days, within 10 days with repetition of a procedure after 20 days. |
|
Composition for prevention of metabolic disorders, increased growth activity in piglets Composition comprises succinic acid, trace elements in the form of sulphates of iron, copper, cobalt, zinc and additionally comprises methionine and beet-root molasses at the following content of components in 1000 ml of an aqueous solution: succinic acid - 5.0 g, beet-root molasses - 150.0 ml, methionine - 2.0 g, ferrous sulphate - 10.0 g, copper sulphate - 0.1 g, cobalt sulphate - 0.5 g, zinc sulphate - 0.5 g. |
|
|
Group of inventions relates to medicine, namely to dermatology and mycology, and can be applied in the treatment of skin and its appendages. A pharmaceutical composition for external application contains nanoparticles for the laser thermotherapy of infectious affections of the skin and its appendages. The nanoparticles are characterised by, at least, one localised surface Plasmon resonance in the range of a wavelength from 400 to 1100 nm. The nanoparticles are dispersed in a physiologically acceptable carrier, which is characterised by the absence of the absorption or weak absorption and/or weak dispersion of light radiation in the said range of wavelengths and possessing biocidal properties. The pharmaceutical composition is applied on an affected area and irradiated by laser radiation with a wavelength close to the wavelength of the localised surface Plasmon resonance of the nanoparticles, contained in the composition, or equal to it. The irradiation is continued until the desirable temperature of heating of the said area is achieved. |
|
Invention refers to pharmaceutical industry, namely to a method for producing a complex compound of dihydroquercetin with metal ions specified in zinc, copper (II) or calcium possessing antioxidant activity. A method consists in the fact that dihydroquercetin and metal salt is mixed in the dry state in a reactor in certain molar ratio; that is followed by adding water at a certain temperature or ethanol or aqueous-alcoholic solution at a room temperature at the controlled medium acidity; using metal salts containing weak acid anions provides medium pH equal to 5.0-5.6; using the metal salts containing strong acid anions requires reducing pH to 7 by adding an alkaline solution; the reaction is completed almost immediately for the first 5 minutes; the precipitation is filtered in water and/or ethanol; dried in air, then in a drying box to constant weight, and a complex compound is produced. The declared method enables reducing the production costs substantially and cheapening the technological process in achieving the target yield with the preset properties. |
|
Disclosed cloth is capable of inactivating viruses falling thereon even in the presence of lipids and proteins regardless of whether or not the viruses have an envelope. The cloth is capable of inactivating viruses falling thereon and includes a cloth base and fine particles of a monovalent copper compound and/or iodide fine particles, wherein the fine particles of a monovalent copper compound and/or iodide fine particles are deposited on said cloth base. The fine particles of the monovalent copper compound are particles of at least one of the following group: chloride, acetate, sulphide, iodide, bromide, peroxide and thiocyanate. The cloth is capable of inactivating different types of viruses. The viruses are inactivated even in the presence of lipids and proteins. |
|
Method of treating chronic constipation and functional anorexia Invention relates to medicine, namely to gastroenterology, and can be used for the treatment of chronic constipation and functional anorexia. For this purpose, as medicinal nutrition used is a milk-vitamin mixture with the following composition (g per 100 g of the product): Proteins 24-26, Fats 27-29, Carbohydrates 33-34, minerals (mg per 100 g of the product), calcium 940-970, phosphorus 780-820, sodium 230-270, potassium 1370-1550, chloride 1270-1350, magnesium 100-125, iron 9.5-10.7, zinc 2.7-3.5, iodine 145-173, copper 76-87, manganese 45-52, vitamins (mcg per 100 g of the product) D3 7.6-8.2, E 6.2-6.8, C 42-46, B1 960-990, B2 1150-1250, Niacin11-15, B6 1370-1440, Folic acid 125-150, Pantothenic acid 2250-2370, B12 1.5-1.9, Biotin 25-31, Choline 40-45. |
|
|
Agent for preventing and treating prostatitis and prostate adenoma Invention represents an agent for preventing and treating prostatitis and prostate adenoma in the form of a capsule, which contains doxazosin, diisopropylammonium dichroloacetate, afobazol, copper glycinate, vitamin E (d-alpha tocopherol acetate), zinc glycinate; L-Glutamine; L-Alanine; L-Arginine and excipients: corn starch and talc. |
|
|
Invention relates to chemical-pharmaceutical industry and represents substitute of bone transplant, containing osteogenic agent and zeolite, which contains particles, containing ion-exchange cations of metals, present in quantity, effective for stimulation of osteogenesis in patient who needs it, in which said metal cations are selected from the group, consisting of zinc ions, silver ions, copper ions and their combinations. |
|
|
Method of treating patients with dental pulp and periodontal diseases Endodontic treatment stage involving retrieval and dilation of a root canal is performed. Gluftored liquid is introduced into the root canal of the tooth. A fibre cable is placed above a tooth canal orifice, and the liquid is reflected by means of a laser light for 30-60 seconds. The root canal is dried with a paper point. Pre-shaken Gluftored suspension is introduced into the root canal. The fibre cable is placed above the tooth canal orifice, and the suspension is reflected by means of the laser light for 30-60 seconds. The root canal is dried and filled. |
|
Method of treating bovine digital dermatitis (dermatitis digitalis) Invention refers to the veterinary science, particularly to substances used in treating purulent-necrotic involvements of bovine's distal extremities, including digital dermatitis. A preparation for treating bovine digital dermatitis in the form of an ointment consists of an excipient, containing an ointment base, and an active ingredient - zinc oxide and copper sulphate in the following proportions, wt %: zinc oxide 9-11, copper sulphate 35-45, the ointment base - the rest. |
|
|
Method of treating bovine digital dermatitis Invention refers to the veterinary science and is applicable for treating bovine digital dermatitis. A method involves applying a preparation in the form of an ointment of the following formulation, wt %: veterinary copper sulphate 35-45, zinc oxide 9-11, an ointment base - the rest. The preparation is made by mixing the ingredients until smooth. The preparation is applied on the involved regions 1-2 times with or without a protective dressing. |
|
|
Invention relates to medicine, namely to a method of preventing complications of rhinitis or an influenza-like syndrome. The method of preventing complications of rhinitis or the influenza-like syndrome consists in the following: an isoosmotic ionic sea water-based solution with osmolarity, equal to 250-350 mOsm/kg, is introduced daily into each nostril of patients suffering from rhinitis or the influenza-like syndrome, and at the remission stage in the certain regimens. |
|
Method of treating destructive forms of chronic periodontitis Invention relates to medicine, namely therapeutic dentistry and may be used for treating destructive forms of chronic periodontitis. That is ensured by administering a therapeutic preparation into a root canal. A sonic phoresis of the therapeutic preparation Beresh plus drops is preceded by coating the skin surrounding a causative tooth with a therapeutic mixture containing the preparation Beresh plus drops, 10% calcium gluconate and Vaseline oil. Thereafter, an emitter is used to process the area. The sonic phoresis is followed by a root canal obturation with calcium hydroxide. That is combined with administering ascorbic acid in a daily dose of 50-100 mg and the preparation Beresh plus drops 1 drop per 2 kg of body weight a day orally. The therapeutic course is 5-8 procedures. |
|
Methods and compositions for treating cancer Invention refers to a kit for lung cancer cell sensitisation to cisplatin. The declared kit comprises a first composition containing a therapeutically effective amount of sodium metaarsenite, and a second composition containing a therapeutically effective amount of cisplatin. Also, the invention refers to using the therapeutically effective amount of sodium metaarsenite for lung cancer cell sensitisation in a patient treated with cisplatin. |
|
Composition for prevention of iron deficiency anemia Invention relates to pharmaceutical industry, and namely to composition for prevention of iron deficiency anemia. Composition for prevention of iron deficiency anemia, which contains source of iron, source of copper, vitamins B1, B3, B6, B9, B12, ascorbic acid, extract from nettle leaves, extract from strawberry leaves, pantohematogen and auxiliary substances, with specified component ratio. |
|
|
Preparation for soft tissue regeneration with antibacterial effect Invention refers to a powdered preparation for soft tissue regeneration with an antibacterial effect. The preparation contains 0.07-0.09 wt % of copper nanoparticles sized 30-40 nm, 0.03-0.05 wt % of zinc nanoparticles sized 30-70 nm, and low-molecular chitosan. |
|
|
Agent for treating diabetes, pharmaceutical composition and method for treating diseases Invention refers to pharmaceutical composition and medicine, and represents a hypoglycemic, hypocholesteremic, hypolipidemic and (or) antioxidant combination of bis-(γ-L-glutamyl)-L-cysteinyl-glycine in the form of disodium salt and lipoic acid in the form of sodium salt, and coordination compounds formed by palladium, copper and γ-L-glutamyl-L-cysteinyl-glycine wherein the molar ratio of bis-(γ-L-glutamyl)-L-cysteinyl-glycine of disodium salt : sodium lipoate : palladium : copper found within the range of 100-10000:100-10000:1-10:1-10. |
|
Method of combination treatment of abscesses in experiment Invention refers to medicine, namely surgery, and may be used for treating abscesses, festered residual cavities and ganglions. The cavity contents are daily aspirated through a catheter in laboratory animals (male rabbits) suffering simulated hepatic abscesses of the diameter of 1.5 cm. Then the abscess cavity is filled with copper nanoparticle suspension in 0.9% physiologic saline of the concentration of 1 mcg/ml. A laser light guide provided with a diffuser is placed in the cavity centre to expose to laser light at wave length 630 nm in a continuous mode, output power 35 mWt for 3 minutes. |
|
Method for correction of immunobiochemical status in ante- and postpartum cows Invention refers to veterinary science. The preparation metallosuccinate 10 ml is introduced intramuscularly three times before calving and two times after every 10 days. |
|
Composition for preventing and treating cancer containing agg albumen with copper vitriol Present invention refers to a composition for preventing or treating cancer containing egg albumen combined with copper vitriol in an effective amount as an agent, as well as to a method for preventing or treating by administering said composition. The invention also refers to a functional health-improving foodstuff for preventing cancer or improving the cancer-associated condition, containing egg albumen and copper vitriol. What is also declared is a method for preparing the composition of egg albumen and copper vitriol wherein the method involves heating and dehydration of copper vitriol until the entire volume of copper vitriol becomes grey, cooling of dehydrated copper vitriol, powdering and mixing with egg albumen. |
|
Electrogenerating particles and use thereof Invention refers to a galvanic particle consisting of zinc, partially copper-plated. A galvanic particle size is equal to nm to 100 mcm, while copper weight therein makes 0.01-10 % of particle weight. The galvanic particles under the invention may be prepared by contact of the zinc particles and a copper salt solution. The invention also refers to a pharmaceutical composition which contains an effective amount of said galvanic particles and a bioabsorbed polymer, and to an oral dosage form containing an effective amount of the galvanic particles under the invention, and a pharmaceutically acceptable carrier. The invention also refers to a method for destruction of drug-resistant microorganisms involving contact of a microorganism and the composition containing the carrier and said galvanic particles. |
|
|
Method for obtaining ionic silver solution Metallic silver is diluted in distilled water till electrolyte is formed. After electrolyte is formed as a result of anodic silver oxidation and self-dilution of oxide, dilution process is interrupted, electrolyte is drained and magnetised by passing it through a glass tube going through magnetic field of constant magnet. Then, at weak mixing of the solution, dilution process of metallic silver is continued till hardly transparent black suspension is formed; after that, the process is stopped. Settled concentrate is separated; in addition, clean electrolyte is magnetised and again brought into circulation, and deposit of crystalline hydrate of silver oxide (1) is used in order to obtain water solution of ionic silver, at which crystalline hydrate is diluted in water, magnetised in magnetic field, filtered and drained to glass bottles to be stored. |
|
Agent showing anxiolytic action Invention refers to medicine, namely clinical pharmacology, and may be used for pharmacological correction of the CNS disease, and concerns the agents showing anxiolytic action. The ingredients of the composition have the following relation, wt %: Magnesium sulphate 77.76835-50.22505; Ferric (II) sulphate 13.73-30.27; Copper (II) sulphate 8.50-19.50; Chromium (III) chloride 0.00165-0.00495. |
|
Method of treating infected wounds in experiment Invention refers to medicine, namely experimental medicine, surgery and aims at treating purulent wound in experiment. A method involves a pre-toilet, application of a dressing containing an iron nanoparticle suspension in the concentration of 0.1 mg/ml and a copper nanoparticle suspension in the concentration of 0.001 mg/ml in 0.9% normal saline prepared by plasma flow of temperature 5000-6000 K. Copper nanoparticle dispersion makes 30 nm, while iron nanoparticle dispersion is 70 nm. |
|
Method of treating abscesses in experiment Invention refers to medicine. A method involves daily abscess cavity sanitation, sanitation liquid evacuation. Then the abscess cavity is filled with a copper nanoparticle suspension in physiologic saline in the concentration of 100 mcg/ml, exposing for 30 min to be evacuated thereafter. |
|
Preparation fastening wound healing Invention refers to medicine. The preparation represents a solution of low-molecular chitosans in hydrogel containing methyl cellulose (MC-100) and Nipagin. The preparation represents a dispersed suspension of copper nanoparticles, particle size 33.8÷103 nm; oxide film thickness 6÷10 nm and phase composition: crystalline copper 67-96% and copper oxide CuO - 4÷33%, or more oxidised copper nanoparticles having the following characteristics: particle size 77÷119 and phase composition: crystalline copper 0.5÷3.3%, CuO - 27.1÷90.0% and Cu2O -9.05÷69.50 in hydrogel containing methyl cellulose (MC-100), Tween-80, Nipagin and the solution of solution of low-molecular chitosans, the suspension of chitosan nanoparticles. |
|
Mixed iron and copper salts masking metallic taste Present invention refers to an oral food additive which contains anhydrous ferric pyrophosphate, ferric pyrophosphate monohydrate or nonahydrate and copper citrate. The invention also concerns a method for preparing said additive and using it for balanced iron intake in the patient. |
|
|
Invention refers to antimicrobial agents exhibiting antibacterial activity with respect to test cultures of gram-positive and gram-negative microorganisms which represent copper nanoparticles and copper oxide nanoparticles. The antimicrobial agents according the invention are characterised by specific particle sizes and phase compositions. The nanoparticles have the size of 33.8-103 nm and contain 67-96% of copper and 4-33% of CuO. The copper oxide nanoparticles have the sizes of 77-124 nm and contain 3.3-23% of crystalline copper, 27.1-90% of CuO and 9.05-69.5% of Cu2O. |
|
Pharmaceutical compositions glp-1 Invention refers to pharmacology and represents a pharmaceutical composition containing the GLP-1 [Aib8,35]hGLP-1 (7-36)NH2 analogue prepared together with a pharmaceutically acceptable salt of said analogue or a mixture of salt of said analogue and the analogue, said composition additionally contains a bivalent metal and/or a bivalent metal salt with the molar ratio of said GLP-1 analogue and said bivalent metal and/or bivalent metal salt in said pharmaceutical composition makes approximately 5.4:1 to approximately 1.5:1; wherein said bivalent metal represents zinc or copper, and wherein the range of the molar ratios of said salts (Aib8.35)hGLP-1 (7-36)NH2 and the GLP-1 peptide analogues makes approximately 0.5:1 to approximately 10:1. |
|
Method of producing concentrates of zerovalent metal dispersions with antiseptic properties Invention relates to a method of producing concentrates of nanodispersions of zerovalent metals such as silver, gold, copper, palladium, platinum and mercury, which have antiseptic properties. Said method involves mixing a solution of a soluble metal salt in a solvent with ammonia to obtain a complex which is then mixed with alkalnolamine to form a solution. The obtained solution is mixed with a solution of a polymer stabiliser to obtain a stabilised metal cation which is then reduced by adding to the solution an organic or inorganic reducing agent to form a stable dispersion of metal nanoparticles. The disclosed method is realised at a defined ratio of components for 10-60 minutes in an air atmosphere at temperature of up to 100°C. |
|
Invention refers to medicine, more specifically clinical pharmacology, and can be used for pharmacological correction of the CNS diseases, and concerns drugs exhibiting psychostimulant action and prepared of inorganic (mineral) raw materials. The agent exhibits psychostimulant action, contains magnesium sulphate, ferric (II) sulphate, copper (II) sulphate and chrome (III) chloride. |
|
Invention refers to medicine and cosmetology, and represents a bactericidal nail care polish containing a water-soluble film-forming hydroxyalkyl chitosan or carboxyalkyl chitosan material, a bactericidal agent, a polar aqueous-alcoholic solvent which as the bactericidal agent contain bentonite powders nanostructured to particle size 150 nm and less, and intercalated by metal ions Ag+ or Ag+ and Zn2+, or Cu2+ and Zn2+, or Ag+ and Cu2+ and Zn2+ which are introduced into a prepared emulsion of the film-forming material in the form of 4-10 % hydrosol; the components of the composition are taken in certain proportions, wt %, and the weight ratio parts of the mixtures of bentonite powders intercalated by metal ions is: for metal ions Ag+ and Zn2+ (1:(0.5÷1)); for metal ions Cu2+ and Zn2+ (1÷0.5):(0.5÷1); for metal ions Ag+ and Cu2+ and Zn2+ 1:(0.5):(0÷1). |
|
Combined preparation for metabolic disorder correction in farm animals Invention refers to agriculture, more specifically to veterinary science. The preparation contains an iron compound with vegetable erythrodextrins, copper sulphate and manganese sulphate, cobalt sulphate, zinc sulphate, sodium selenit, potassium iodite, enzyme milk albumin hydrolysate, yeast extract, phenol and distilled water in certain proportions. |
|
|
Method for producing biocide consists in Na-form bentonite activation by sodium ions by means of processing with an aqueous solution of sodium chloride followed by chlorine anion removal with washing and filtration of the prepared raw material. Thereafter, the prepared raw material is intercalated by bactericidal metal ions by processing of inorganic salts in aqueous solutions: silver nitrate, copper sulphate, zinc sulphate or nitrate; sodium salts are removed by washing of the biocide product with deionised water; then the product is filtered, dried and grinded to particle size 20-150 nm. The activation and intercalation processes are performed by exposure to ultrasound at frequency 20-50 kHz and intensity 10-100 Wt/cm2, and the purification process of the intercalated product from sodium salts is two-staged: at first, the product is decanted, and then washed in deionised water containing 30 "ppm" - 100 "ppm" of an alkaline metal ion complexing agent of crown-ethers of molecular weight 264 and less. |
|
Antiseptic ointment for outward application (2 versions) According to the first version, an antiseptic ointment contains a base and an antiseptic agent in the form of an Ag+ or/and Cu2+ intercalated disperse bentonite powder which is produced by modification of Na+ preliminary enriched bentonite by aqueous solutions of silver nitrate or copper sulphate. A base is medical Vaseline or mixed medical Vaseline and lanolin and additionally contains a vegetable essential oil. The antiseptic ointment according to the second version contains a base and an antiseptic agent in the form of Ag+ or/and Cu2+ intercalated bentonite powders and a Zn2+ intercalated bentonite powder which is produced by modification of prepared raw Na+ enriched bentonite processed by solutions of inorganic salts of zinc chloride (ZnCl2) or zinc sulphate (ZnSO4), cleared from sodium salts and dispersion. A base is medical Vaseline or mixed medical Vaseline and lanolin and additionally contains a vegetable essential oil. |
|
|
Medication for treatment and prevention of fungal skin diseases Invention relates to medication in form of ointment for treatment and prevention of fungal skin diseases. Claimed medication as antifungal agents contains bifonasol in amount 0.9-1.1 wt %, 6-10 wt % of stabilised sol of silver nanoparticles and 6-10 wt % of stabilised sol of copper nanoparticles, and as base, it contains mixture of polyethylene oxides (400, 1500, 2000 and 4000) and water. |
|
|
Mixed iron and copper salts masking metallic taste Present invention refers to chemical-pharmaceutical industry, namely to preparing an oral food additive free from taste masking substances and containing a iron and copper source. |
|
|
Optomised vitamin-mineral complex Invention relates to field of pharmaceutical and food industry, in particular to production of vitamin-mineral complexes (VMC) and food additives, used for prevention and treatment of vitamin-mineral deficiency. Simultaneously, taken into account are all antagonistic and synergic interactions between active VMC components, arising in production, storage and application of medication. Delivery of micronutrients by time and place of their digestion is realised within one preparative form, which is made in form of tablet or capsule, containing several independent elements - pellets. Pellets have their time of dissolution, depending on acidity of surrounding medium. During movement of ready form along GIT time of beginning of substances release from one pellet follows time of end of substances release from other pellet in such a way that simultaneously in solution there were no active substances that have antagonistic interaction. |
|
|
Method of producing aqueous copper-silver compositions Invention relates to producing aqueous copper-silver compositions. Proposed method comprises dissolving silver oxide in distilled water in amount of 13·10-3 g per litre, cooling or heating of obtained solution to 20°C, solution settling and filtering. Then, obtained solution is used partially for producing copper ions by chemical rejection of silver from solution by metallic copper, filtration of copper solution, combining two solutions in one and additional filtration of prepared compositions. |
|
|
Invention refers to agents for treating locomotive diseases in human and animals. The agent represents a colloidal solution of an aqueous suspension of a sea mineral composition of microparticle size 106-107 m with an active surface of micelle microparticles no more than 500 m2/ml and density of the aqueous suspension not exceeding 1.7 kg/l, in the following proportions, wt %: mineral composition 58, water - the rest; the mineral composition contains solid macroelements - chemical chalk and magnesium carbonate, and microelements: zinc, iron, silicon, copper, iodine, etc. in the certain proportions. |
|
Bactericidal composition for prevention and treatment of infectious diseases of hoofs in animals Invention relates to veterinary. Bactericidal composition for prevention and treatment of infectious diseases of hoofs in animals, includes stabilised sol of copper, zinc and silver nanoparticles, methylene blue, as well as polyethyleneglycole-4000, polyvinylpyrrollidone, cellulose, formic and lactic acids, purified water with specified component ratio. |
|
|
Invention refers to medicine and biology, particularly to biological preparations and can find application for healing of wounds, burns, treatment of tumours and correction of metabolic processes. In a germicide containing powder metal particles, as a metal, copper is used that represents a suspension in 0.9% NaCl of powder particles prepared of coarse metal particles exposed to plasma stream at temperature 5000°-6000°K, particle size 30-40 nm and suspension concentration 0.001 mg/ml. |
|
|
Medication and method of treating necrotic suppurative diseases of animal extremities Invention relates to field of veterinary, in particular to means and methods of treating necrotic suppurative diseases of animal extremities, such as necrobacteriosis, footrot, suppurative pyodermatites, laminites, Rustergolts ulcers, etc. Claimed medication represents nanostructured composition in form of suspension, containing clathrate of didecyldimethylammonium halagenide with carbamide, copper vitriol, tar, pharmaceutically acceptable monoatomic alcohol and water. Also described is method of treating necrotic suppurative diseases of animal extremities which lies in the following: extremities of animals are treated with efficient amount of medication 1 time a day during 7-10 days in form of external applications and/or foot baths. |
|
|
Immunocorrecting preparation for farm animals and poultry Immunocorrecting preparation contains levamisole, vitamins, microelements and bentonite clay in the following ratio, g/kg: levamisole -75-80; vitamin A - 0.35-0.40; vitamin C - 0.2-0.3; zinc - 9.0-10.0; copper - 0.5-0.6; iron - 1.5-2.0; selenium - 0.03-0.04; bentonite clay - the remaining part. Application of claimed preparation by adding to animal and poultry forage produces expressed stimulating impact on immunocompetent systems of organism, which, in its turn, contribute to enhancement of protective functions of organism and increase of animal productivity and safety. |
|
|
Pharmaceutical composition for prevention and treatment of menopause osteoporosis in women Invention refers to chemical-pharmaceutical industry and medicine, namely to pharmaceutical compositions for the oral medical products applied in the integrated treatment of menopause osteoporosis in women. There is offered pharmaceutical composition which contains one or more active substances mainly with different therapeutic modalities providing intensified osteogenesis or decreased bone resorption, an element-vitamin complex containing elements in the form of physiologically acceptable compounds, providing intensified bone formations and decreased bone resorption, and the vitamins intensifying therapeutic action of the active substances and ensuring intensified bone formation and decreased resorption, and an excipient in the form of one substance or mixed substances which is monoexcipient or one component of the excipient. |
|
|
Biologically active preparation Invention concerns medicine and biology, particularly biological preparations, and can find application in treatment of wounds, burns, tumours and correction of metabolic processes. The problem whereat the declared invention aims, is improving the clinical effectiveness for wide spectrum of inflammatory diseases, particularly, reduced time for achievement of medical effect and/or prolongation of remission periods and increased resistance of the patients to infections. The task in view is solved by that a biologically active preparation represents a suspension of particles of powdered copper, iron and zinc made of the alloy exposed to the plasma flux at temperature 5000-6000°K, in 0.9% NaCl solution in the weight ratio Cu:Fe:Zn=60:15:25, dispersion of particles 180-220 nm and concentration of the suspension equal of 10 mg/ml. |
|
Method of treating hairy skin psoriasis Invention concerns medicine, namely dermatology and can be used for treating hairy skin psoriasis. That is ensured by application of an anti-dandruff shampoo on the basis of surface-active substances with a metal-polymeric composition MPC-3K during 15-25 procedures every second day. The shampoo is soaped over the skin within lesion region and left for 8-10 minutes. Then it is rinsed with warm water with a conditioner containing the metal-polymeric composition MPC-3K. After application and soaping, a protective cap is put on. |
|
|
Medicine for prevention and treatment of diseases of fur covering of carnivorous animals Invention relates to veterinary. Medicine for prevention and treatment of diseases of fur covering of carnivorous animals includes copper sulfate - 0.5%, DL- methionine - 2%, tricalciumphosphate - 20%, nutrient yeasts - to 100%. |
|
|
Invention refers to chemical-pharmaceutical industry and can be used for prevention and treatment of menopausal disorders, namely to liquid and soft dosage forms of Sygethin preparation. The local and external pharmaceutical composition contains Sygethin, a target additive and a base. The target additive is hypooxidant, e.g. either succinic acid, or vitamins, or biogenic elements as physiologically acceptable compounds, or their physiologically acceptable mixtures. The composition represents a liquid dosage form that is suspension or emulsion, or s a soft dosage form including cream, ointment or gel, or as a formed soft dosage form being rectal or vaginal suppository or capsules. |
|
|
For treatment of traumatological and neurosurgical diseases ceruloplasmin is included in treatment scheme. Single daily introduced dose is 6-8 mg/kg, depending on child's age, per 200 ml of 0.9% of sodium chloride solution. Medication is introduced by intravenous drip at rate 20-25 drops a minute for not less than 12 days. |
Another patent 2551210.